Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28,444 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial.
Udwadia ZF, Singh P, Barkate H, Patil S, Rangwala S, Pendse A, Kadam J, Wu W, Caracta CF, Tandon M. Udwadia ZF, et al. Among authors: wu w. Int J Infect Dis. 2021 Feb;103:62-71. doi: 10.1016/j.ijid.2020.11.142. Epub 2020 Nov 16. Int J Infect Dis. 2021. PMID: 33212256 Free PMC article. Clinical Trial.
Response to the comments received on article "Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial" by Udwadia et al.
Udwadia ZF, Barkate H, Patil S, Rangwala S, Wu W, Caracta CF, Tandon M. Udwadia ZF, et al. Among authors: wu w. Int J Infect Dis. 2021 Apr;105:686-687. doi: 10.1016/j.ijid.2021.02.028. Epub 2021 Feb 15. Int J Infect Dis. 2021. PMID: 33601032 Free PMC article. No abstract available.
Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial.
Salvi S, Balki A, Krishnamurthy S, Panchal S, Patil S, Kodgule R, Khandagale H, Pendse A, Wu W, Rangwala S, Tandon M, Barkate H. Salvi S, et al. Among authors: wu w. ERJ Open Res. 2021 Jul 26;7(3):00255-2021. doi: 10.1183/23120541.00255-2021. eCollection 2021 Jul. ERJ Open Res. 2021. PMID: 34322547 Free PMC article.
Evaluation of the Safety and Efficacy of Favipiravir in Adult Indian Patients with Mild-to-Moderate COVID-19 in a Real-World Setting.
Reddy PK, Patil S, Khobragade A, Balki A, Raj A, Kalikar M, Reddy R, Shinde R, Cr J, Mutha A, Boyilla N, Rajadhyaksha GC, Karnik N, Bhagat S, Pendse A, Dhage P, Wu W, Rangwala S, Barkate H. Reddy PK, et al. Among authors: wu w. Int J Gen Med. 2022 May 3;15:4551-4563. doi: 10.2147/IJGM.S349241. eCollection 2022. Int J Gen Med. 2022. PMID: 35535140 Free PMC article. Clinical Trial.
Comparative efficacy and safety of glycopyrronium/formoterol fixed-dose combination versus glycopyrronium monotherapy in patients with moderate-to-severe COPD.
Salvi S, Jain MK, Krishnamurthy S, Balki A, Kodgule R, Tandon M, Bhagat S, Panchal S, Khatri N, Wu W, Pendse A, Patil S, Barkate H. Salvi S, et al. Among authors: wu w. Lung India. 2022 Nov-Dec;39(6):517-524. doi: 10.4103/lungindia.lungindia_136_22. Lung India. 2022. PMID: 36629230 Free PMC article.
Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia - An Observational Real-World Clinical Study.
Fifer S, Toh L, Barkate H, Aggarwal V, Borade D, Gordonsmith RH, Wu W, Morgan C, Young K. Fifer S, et al. Among authors: wu w. Patient Prefer Adherence. 2023 Jan 15;17:141-151. doi: 10.2147/PPA.S389875. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 36687019 Free PMC article.
28,444 results
You have reached the last available page of results. Please see the User Guide for more information.